Mylan Labs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mylan Labs

MYL 15.86

0.0%

Nov 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: B. W. Lewis who wrote (309)	5/11/1998 12:44:00 PM
From: StockDoc	Read Replies (1) of 384

BWL Records suggest that ELN entered into some deal with EMIS in 95 on oral heparin. In what development stage was EMIS' heparin program (preclinical, IND?, phase I?), when ELN licensed the technology for heparin? I would like to figure what EMIS can deliver in 3 years so that I can make projections about their abilities. There are a bunch of crooks in this delivery field. I was dumb and bought shares from a controlled release injection company without checking whether the officers were sane. Got out just in time barely making any money before they fell. I don't want to depend or loose on another management, like DEPO has, again, and don't want to be on a constant alert. Do ELN's officers have control over this program? What's your expected annual return on ELN is? I hope Mylan goes at the same pace as it started this year. StockDoc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next